Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.

International journal of molecular sciences - 14 May 2024

Naber Annemieke, Demus Daniel, Slieker Roderick C, Nicolardi Simone, Beulens Joline W J, Elders Petra J M, Lieverse Aloysius G, Sijbrands Eric J G, 't Hart Leen M, Wuhrer Manfred, van Hoek Mandy

Abstract excerpt

Apolipoprotein-CIII (apo-CIII) inhibits the clearance of triglycerides from circulation and is associated with an increased risk of diabetes complications. It exists in four main proteoforms: O-glycosylated variants containing either zero, one, or two sialic acids and a non-glycosylated variant. O-glycosylation may affect the metabolic functions of apo-CIII. We investigated the associations of apo-CIII...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoprotein C-III

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Diabetic Angiopathies

Share to Diabetic Retinopathy

Share to Glycosylation

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 38791405
DOI: 10.3390/ijms25105365
PMCID: PMC11121677

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.PMID 38791405Read ↗

Insights into the molecular underpinning of type 2 diabetes complicationsSemantic proximity Read ↗

Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analysesSemantic proximity Read ↗

Replication of 10 novel loci involved in human plasma protein N-glycosylation using MALDI-MS and UHPLC-FD dataSemantic proximity Read ↗

Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) StudySemantic proximity Read ↗

Mechanisms of disease: The human N-glycomeSemantic proximity Read ↗

Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetesSemantic proximity Read ↗

N-glycosylation signature and its relevance in cardiovascular immunometabolismSemantic proximity Read ↗

Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis.Semantic proximity Read ↗

Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.Semantic proximity Read ↗

Variation of IgG N ‐linked glycosylation profile in diabetic retinopathySemantic proximity Read ↗

A genome-wide association study in 10,000 individuals links plasma N-glycome to liver disease and anti-inflammatory proteinsSemantic proximity Read ↗

A genome-wide association study in 10,000 individuals links plasma N-glycome to liver disease and anti-inflammatory proteinsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.